Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03730103 · ClinicalTrials.gov registry record · NA
Same Day Discharge After Minimally-invasive Sacrocolpopexy
A NA study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- NA
- Development phase
- 52
- Enrollment target
NCT03730103 is a NA study that has completed, run by The Cleveland Clinic. The registered enrollment target is 52 participants.
The verdict
NCT03730103, a NA study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 52 participants
- Enrollment target
Study Summary
This is a prospective cohort study evaluating safety, cost and patient satisfaction with SDD for patients undergoing minimally invasive sacrocolpopexy for pelvic organ prolapse. A prospectively collected, historical control group who underwent the same surgical procedure will be utilized to compare these outcomes when applicable. SDD will be facilitated in part by a utilizing novel patient education video created for this study and implementing an ERAS pathway. All patients meeting eligibility criteria will be approached for study participation. Outcomes will be assessed on POD 0/1 and at the routine post-operative follow up visit, generally at 6 weeks after surgery.
Interventions
- OTHER Same day discharge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2018-10-22 |
| Est. Completion | 2020-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03730103
The ClinicalTrials.gov registry entry for NCT03730103 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Same day discharge is the first listed.
NCT03730103 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03730103 about?
NCT03730103 is a clinical study titled "Same Day Discharge After Minimally-invasive Sacrocolpopexy". This is a prospective cohort study evaluating safety, cost and patient satisfaction with SDD for patients undergoing minimally invasive sacrocolpopexy for pelvic organ prolapse. A prospectively collected, historical control group who underwent the same surgical procedure will be utilized to compare ...
What is the current status of trial NCT03730103?
This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2018-10-22. Estimated completion is 2020-06-01.
What interventions are being tested in trial NCT03730103?
The interventions under investigation include: Same day discharge (OTHER).
Who is sponsoring clinical trial NCT03730103?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.